Status:
COMPLETED
Paternal Age and Fetal Aneuploidy
Lead Sponsor:
Clinique Ovo
Conditions:
Trisomy 21
Eligibility:
FEMALE
18+ years
Brief Summary
Trisomy 21, commonly known as down syndrome, is the most common chromosomal abnormality in humans. Advanced maternal age (AMA) is a well-recognized risk factor for trisomy 21, with the risk increasing...
Eligibility Criteria
Inclusion
- Pregnant women aged 18 years or older (at the time of trisomy 18 and 21 screening) and who were able to complete the questionnaire in either French or English
- Pregnant women who completed the entire trisomy 21 screening process at clinique ovo were included
Exclusion
- Patients who did not indicate the male partner/donor's age were excluded
- Patients who did not complete or sign the clinical information form
Key Trial Info
Start Date :
July 31 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 13 2025
Estimated Enrollment :
7141 Patients enrolled
Trial Details
Trial ID
NCT05981521
Start Date
July 31 2023
End Date
June 13 2025
Last Update
December 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique Ovo
Montreal, Quebec, Canada, H4P 2S4